We are live on ! Find out more
SIG

Sargent Investment Group Portfolio holdings

AUM $759M
1-Year Est. Return 28.58%
This Fund
S&P 500
This Quarter Est. Return
+3.97%
1 Year Est. Return
+28.58%
3 Year Est. Return
+104.74%
5 Year Est. Return
+107.13%
10 Year Est. Return
AUM
$490M
AUM Growth
+$34.1M
Cap. Flow
+$23.6M
Cap. Flow %
4.81%
Top 10 Hldgs %
38.63%
Holding
229
New
28
Increased
88
Reduced
79
Closed
9

Sector Composition

Rank Sector Weight
1 Technology 26.04%
2 Financials 11.51%
3 Healthcare 9.26%
4 Industrials 6.53%
5 Consumer Discretionary 4.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TR icon
201
Tootsie Roll Industries
TR
$2.99B
$214K 0.04%
7,409
+215
+3% +$6.07K
AVB icon
202
AvalonBay Communities
AVB
$27.1B
$212K 0.04%
+1,025
New +$198K
SPY icon
203
State Street SPDR S&P 500 ETF Trust
SPY
$819B
$211K 0.04%
+387
New +$203K
KO icon
204
Coca-Cola
KO
$374B
$210K 0.04%
3,295
-45
-1% -$2.79K
RSP icon
205
Invesco S&P 500 Equal Weight ETF
RSP
$99.3B
$207K 0.04%
1,260
+35
+3% +$5.76K
VOE icon
206
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
$206K 0.04%
1,367
-3,300
-71% -$501K
NOW icon
207
ServiceNow
NOW
$121B
$205K 0.04%
+1,305
New +$191K
FOF icon
208
Cohen & Steers Closed End Opportunity Fund
FOF
$378M
$180K 0.04%
15,085
JYNT icon
209
The Joint Corp
JYNT
$119M
$150K 0.03%
+10,680
New +$152K
AKTS
210
DELISTED
Akoustis Technologies Inc
AKTS
$120K 0.02%
913,800
-757,350
-45% -$285K
OM icon
211
Outset Medical
OM
$94.9M
$99.3K 0.02%
1,720
-25
-1% -$1.23K
CHRS icon
212
Coherus Oncology
CHRS
$224M
$74.6K 0.02%
43,130
-5,570
-11% -$11.2K
RLMD icon
213
Relmada Therapeutics
RLMD
$571M
$64.4K 0.01%
21,460
-358
-2% -$1.29K
LONA
214
LeonaBio Inc
LONA
$72.1M
$51.7K 0.01%
1,952
-23
-1% -$542
BLUE
215
DELISTED
bluebird bio
BLUE
$37.9K 0.01%
1,926
-25
-1% -$501
DNA icon
216
Ginkgo Bioworks
DNA
$612M
$36.9K 0.01%
2,759
-2,758
-50% -$82.3K
RVNC
217
DELISTED
Revance Therapeutics, Inc.
RVNC
$33K 0.01%
12,847
-48
-0.4% -$164
CBIO
218
Crescent Biopharma
CBIO
$586M
$28.2K 0.01%
1,000
-80
-7% -$8.32K
ASRT
219
DELISTED
Assertio
ASRT
$19.8K ﹤0.01%
1,063
-1,928
-64% -$28.7K
TELL
220
DELISTED
Tellurian Inc.
TELL
$10.4K ﹤0.01%
15,000
DE icon
221
Deere & Co
DE
$165B
-949
Closed -$390K
DOW icon
222
Dow Inc
DOW
$21.4B
-3,685
Closed -$213K
NUE icon
223
Nucor
NUE
$62.6B
-1,266
Closed -$251K
SHOP icon
224
Shopify
SHOP
$187B
-3,631
Closed -$280K
STAG icon
225
STAG Industrial
STAG
$7.19B
-5,422
Closed -$208K

Similar funds

Sargent Investment Group's Q2 2024 Portfolio in Review

As of Q2 2024, Sargent Investment Group held 229 positions worth $490M, up 7.5% from $456M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Sargent Investment Group deployed $23.6M of net new capital in Q2 2024, opening 28 new positions and adding to 88 existing holdings. Its largest new stake was Wheaton Precious Metals: 21,302 shares worth $1.12M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was GE Aerospace, an estimated $806K trimmed.

  • Sargent Investment Group's largest Q2 2024 buy was Wheaton Precious Metals: 21,302 shares worth $1.12M.
  • Sargent Investment Group added most to AbbVie in Q2 2024, an estimated $6.84M increase.
  • Sargent Investment Group's biggest Q2 2024 reduction was GE Aerospace, cutting an estimated $806K.
  • Sargent Investment Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $811K.
  • Sargent Investment Group's ten largest holdings make up 39% of its $490M portfolio in Q2 2024.
  • Sargent Investment Group opened 28 new positions and closed 9 in Q2 2024.
  • Sargent Investment Group's portfolio value rose 7.5% quarter-over-quarter to $490M.

Based on Sargent Investment Group's 13F filing for Q2 2024, filed 9 Aug 2024.